Applying Implementation Science in the Field of Transplant and Cellular Therapy
Anna M. DeSalvo(National Marrow Donor Program), Jeffery J. Auletta(Nationwide Children's Hospital), Mary Hengen(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Meggan McCann(National Marrow Donor Program), Rafeek A. Yusuf(National Marrow Donor Program), Delilah Robb(National Marrow Donor Program), Jennifer A. Sees(National Marrow Donor Program)
Cited by 5
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442